—

PACS Group, Inc. (PACS) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

PACS Group, Inc. ranks 5 of 8 in its cohort on the Closelooknet composite (54/100) — the cohort is led by DexCom Inc at 65/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
PACS PACS Group, Inc. 54 67 41 56 info 13.5%
FMS Fresenius Medical Care Corporation 51 43 37 84 info 15.6%
ENSG The Ensign Group Inc 48 34 37 45 warn 21%
RHC.AU Ramsay Health Care Ltd 45 89 24 53 ok 2.3%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%
MEDP Medpace Holdings Inc 63 79 76 30 ok 11.1%
REGN Regeneron Pharmaceuticals Inc 60 56 72 51 watch 15.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are PACS Group, Inc.'s peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Fresenius Medical Care Corporation (FMS), The Ensign Group Inc (ENSG), Ramsay Health Care Ltd (RHC.AU), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP), Regeneron Pharmaceuticals Inc (REGN).

How does PACS score against its peers?

PACS Group, Inc.'s composite reads 54/100, ranking 5 of 8 in its cohort as of 2026-10-06; the cohort's highest composite is DexCom Inc at 65/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.